Robert Vassar

Active 1989–2025

108
Papers
28,783
Citations
73
h-index
102
i10-index

Citations

Citations per year for Robert Vassar1962: 1 citations1989: 5 citations1990: 9 citations1991: 19 citations1992: 36 citations1993: 53 citations1994: 70 citations1995: 50 citations1996: 78 citations1997: 60 citations1998: 71 citations1999: 85 citations2000: 155 citations2001: 223 citations2002: 234 citations2003: 189 citations2004: 264 citations2005: 226 citations2006: 265 citations2007: 257 citations2008: 282 citations2009: 284 citations2010: 335 citations2011: 356 citations2012: 377 citations2013: 333 citations2014: 402 citations2015: 386 citations2016: 453 citations2017: 409 citations2018: 377 citations2019: 1,004 citations2020: 1,055 citations2021: 1,030 citations2022: 848 citations2023: 715 citations2024: 1,038 citations2025: 661 citations2026: 22 citations2027: 1 citations1963–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,085 citing papers, 31.1% of this breakdownChina: 1,295 citing papers, 9.9% of this breakdownGermany: 815 citing papers, 6.2% of this breakdownUnited Kingdom: 701 citing papers, 5.3% of this breakdownJapan: 513 citing papers, 3.9% of this breakdownIndia: 435 citing papers, 3.3% of this breakdownItaly: 423 citing papers, 3.2% of this breakdownSouth Korea: 390 citing papers, 3% of this breakdownCanada: 386 citing papers, 2.9% of this breakdownFrance: 338 citing papers, 2.6% of this breakdownSpain: 308 citing papers, 2.4% of this breakdownAustralia: 298 citing papers, 2.3% of this breakdown
0%31.1%Other 23.9%

Fields

  • Medicine55.3%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Neuroscience18.3%
  • Computer Science3%
  • Immunology and Microbiology1.2%
  • Agricultural and Biological Sciences0.7%
  • Other2.8%

Topics

  • Alzheimer's disease research and treatments18.8%
  • Cholinesterase and Neurodegenerative Diseases5.9%
  • Neuroinflammation and Neurodegeneration Mechanisms5.1%
  • Computational Drug Discovery Methods5%
  • Neuroscience and Neuropharmacology Research2.6%
  • Tryptophan and brain disorders2.2%
  • Other60.4%

Coauthors

All papers

Open in search
  1. Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

    Authors: , , , , , , , , , , , - Journal of Neuroscience 2006 cited by 3,581

  2. The β-Secretase BACE1 in Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Biological Psychiatry 2020 cited by 666

  3. The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored

    Authors: , , - Molecular Neurodegeneration 2023 cited by 265

  4. APP mouse models for Alzheimer's disease preclinical studies

    Authors: , , , , , , , , , - The EMBO Journal 2017 cited by 785

  5. β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 1999 cited by 3,836

  6. The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yue‐Ming Li - Nature 2020 cited by 394

  7. Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation

    Authors: , - Molecular Neurodegeneration 2013 cited by 414

  8. AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease

    Authors: , , , , , , , , , , , , - Journal of Biomedical Informatics, J. Biomed. Informatics 2023 cited by 63

  9. The Alzheimer's disease Beta-secretase enzyme, BACE1

    Authors: , - Molecular Neurodegeneration 2007 cited by 545

  10. Targeting the β secretase BACE1 for Alzheimer's disease therapy

    Authors: , - The Lancet Neurology 2014 cited by 624

  11. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease

    Authors: , , , , , , , , , , , , , - Nature Reviews Neurology 2021 cited by 135

  12. The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis

    Authors: , , - Journal of Neuroinflammation 2011 cited by 360

  13. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease

    Authors: , , , , , - Acta Neuropathologica 2016 cited by 296

  14. Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer’s disease model mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Wirths, Jens Wiltfang, Sarah Jäkel, Riqiang Yan, Klaus‐Armin Nave - Nature Neuroscience 2024 cited by 101

  15. The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms

    Authors: , , , , , , , , , - Molecular Neurodegeneration 2023 cited by 56

  16. The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential

    Authors: , , , - Journal of Neuroscience 2009 cited by 576

  17. Endothelial BACE1 Impairs Cerebral Small Vessels via Tight Junctions and eNOS

    Authors: , , , , , , , , , , , , , , , , , - Circulation Research 2022 cited by 76

  18. The secretases: enzymes with therapeutic potential in Alzheimer disease

    Authors: , , - Nature Reviews Neurology 2010 cited by 787

  19. BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

    Authors: - Alzheimer s Research & Therapy 2014 cited by 416

  20. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1

    Authors: , , , , , , , - European Journal of Neuroscience 2006 cited by 303

  21. The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

    Authors: , , , , , - Acta Neuropathologica 2013 cited by 241

  22. Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model

    Authors: , , , , , - Journal of Biological Chemistry 2012 cited by 227

  23. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease

    Authors: , , , , , , , , , , - PLoS Genetics 2017 cited by 162

  24. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models

    Authors: , , , , , , , - Acta Neuropathologica Communications 2015 cited by 78